Biography
Main responsibilities
Sue Amies-King was appointed as an independent non-executive director of Aviva Investors Holdings Limited Board in March 2022. She is also a member of the Aviva Investors Holdings Limited Audit, Risk, Nomination & Remuneration Committees.
Experience and qualifications
Sue has significant experience in the Financial Services sector having spent 8 years at Aviva’s UK Life business and 5 years as an independent non-executive director at a personal lines insurer. She started her career in the energy industry and then moved into financial services in 2004, spending 8 years at Aviva in operational and transformation roles. Sue spent the last 7 years of her executive career in the Water sector initially as a member of the executive team of United Utilities, a FTSE 100 company and then as CEO of a joint venture company called Water Plus which she established. Sue is an independent non-executive director and chair of the Customer Conduct Committee for Hastings Direct Insurance Ltd and an independent consultant advising companies on Business Transformation.
Related profiles

Nick Amin
Non-Executive Director
View profile

Mark White
Independent Non-Executive Director and Chairman of Aviva Investors UK Fund Services Ltd
View profile

Mike Craston
Non-Executive Director of Aviva plc
View profile

Jeffrey Weingarten
Chairman of Aviva Investors North America Holdings Board
View profile

Andrew Kirton
Independent Non-Executive Director
View profile

Alexa Coates
Independent Non-Executive Director
View profile
We know what it takes to make a difference
It takes working together to drive sustainable transition across People, Climate, and Earth. It takes Aviva Investors.

You might also be interested in

Strategies to change the financial system: An interview with Natalie Mangondo
16 Aug. 2022
Can society reform the system that has enabled growth but simultaneously brought the long-term health of the planet into question? UN Climate Change High Level Champions Finance Youth Fellow Natalie Mangondo contemplates choices and change with AIQ.
Read more

Zero-COVID: China’s costly policy error
10 Aug. 2022
Beijing’s ideological battle to stamp out COVID-19 appears increasingly misguided as the rest of the world learns to live with the virus. But the impact of China’s approach will be felt far beyond its borders.
Read more

Illiquidity premia in real assets: Q2 2022
9 Aug. 2022
Our real assets research team crunch the data to see whether the effects of rising inflation and interest rates are being reflected in private market returns.
Read more

What does the data say? Are we close to 1970’s-style stagflation?
29 Jul. 2022
In this month’s instalment of our visual series on topical themes, we look at whether the global economy is heading towards stagflation.
Read more

Multi-asset allocation views: Is this the end of the 60/40 strategy?
20 Jul. 2022
Government bonds have not acted as safe haven assets recently. Sunil Krishnan explores whether this spells the end of the traditional 60/40 allocation in multi-asset portfolios.
Read more

The AIQ Podcast: Taking stock of nature risk
15 Jul. 2022
The idea that human actions are bringing natural systems close to breakdown, threatening livelihoods and financial stability, is making asset managers think harder about nature risk and the environmental dependencies in investee companies.
Read more

EMD: On the bread line
6 Jul. 2022
Russia’s war in Ukraine has contributed to soaring food prices, supercharging global inflation. Poorer countries will likely be hardest hit, adding to the risk of social unrest. With public finances and incomes already under strain, emerging-market debt investors should be on high alert.
Read more

Investing in a just transition to net zero: A Q&A with Nick Robins
30 Jun. 2022
Reaching net zero by 2050 will require significant injections of capital. But it is also an opportunity to rethink social relationships, as Professor Nick Robins explains.
Read more

Supply chains, painkillers and gene editing: ESG risks in pharma
29 Jun. 2022
Reflecting on ESG risks in the pharmaceutical industry, Sora Utzinger discusses supply chains and counterfeit medicines, access to painkillers, and the ethics of gene editing.
Read more

What does the data say? Biodiversity loss: From horror to hope
24 Jun. 2022
In this month’s instalment of our visual series on topical themes, we explore the world of biodiversity.
Read more

ESG investing: Lasting lessons from Russia’s war on Ukraine
23 Jun. 2022
Russia’s invasion of Ukraine has led to ESG receiving widespread flak. While much of the criticism is unjustified, the episode underlines how many issues related to ESG are complex and involve trade-offs. Investment approaches may need fine tuning, especially if the geopolitical landscape continues to change so rapidly.
Read more

Antimicrobial resistance: Q&A with Dame Sally Davies
10 Jun. 2022
Resistance to antibiotics is already killing millions. Professor Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, spoke to AIQ on the latest developments to counter antimicrobial resistance Antimicrobial Resistance (AMR) in the UK and globally.
Read more

The AIQ Podcast: Investing towards a new social contract
9 Jun. 2022
As life returns to some form of normality, governments are free to move their focus from COVID-19 to left-behind communities and delivering a just transition. This is important to secure long-term economic outcomes, but also comes with investment opportunities and risks.
Read more

Deep water: Ten threats to marine ecosystems
8 Jun. 2022
Our air, weather, food, the health of diverse marine life and millions of jobs all depend on the ocean. But we have not done well as custodians of marine ecosystems. Here, we set out ten ways where human actions threaten the health of an essential environment.
Read more

Multi-asset allocation views: Central banks’ delicate balancing act
6 Jun. 2022
With high levels of inflation persisting around the world, central banks must tighten policy without hurting consumer demand and economic growth. This will be more difficult for some central banks than others, says Sunil Krishnan.
Read more

Our progress towards net zero in real assets: A Q&A with Ed Dixon
30 May 2022
One year on from publishing our 2040 net-zero pathway for real assets, Ed Dixon talks through some of the key highlights, challenges and priorities for 2022.
Read more